MS 209
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MS 209, covering 2012-09-24 to 2012-09-24. Get the full timeline:
Most recent: Clinical Trial Update: MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors [Phase 1]